A decades-long investment in basic science research, focus on diversity in clinical trials, and coordinated efforts to repurpose therapeutics and develop diagnostics were among the factors that contributed to the US National Institutes of Health–led response to COVID-19, according to a report published in Science by several authors including Francis […]
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched a Phase 1 clinical trial evaluating three experimental HIV vaccines based on a messenger RNA (mRNA) platform—a technology used in several approved COVID-19 vaccines. NIAID is sponsoring the study, called HVTN 302, […]
Officials at the US National Institute of Allergy and Infectious Diseases, the agency run by Anthony Fauci, MD, issued a statement overnight calling into question the completeness of COVID-19 vaccine data that AstraZeneca shared in its interim phase 3 efficacy and safety findings. Reactions from experts were swift. Some stand […]
